Swisschems

Company Overview

Swisschems was founded in 2018 and operates a US-based business using an Iceland (.is) domain. The company sells a broad catalog of research chemicals including SARMs, peptides, and nootropics. They are positioned in the research chemical market rather than the supplement market — products carry “for research purposes only” labels.

Products & Pricing

Product	Format	Price	Note
BPC-157	Lyophilized powder	~$36.95	Competitive pricing
TB-500	Lyophilized powder	~$40–55	Research chemical format
Various SARMs	Liquid/capsule	$30–80	Core product line
Nootropics	Various	$25–60	Secondary line

Pricing is significantly lower than oral supplement vendors — BPC-157 at ~$37 vs $150+ from Integrative Peptides or Infiniwell. This reflects the research chemical market’s different cost structure (no capsule formulation, no SNAC, no supplement branding).

Transparency Assessment

Score: 50/100 — Claims third-party testing with COAs, though independent reports conflict on verification status. One source noted that lab verification was “not currently available” at the time of review. COA documentation practices appear inconsistent across product lines.

Testing & Quality

Score: 55/100 — Frequently cited on Reddit as “dependable” for SARMs, which is their primary product category. Peptide testing and quality may receive less focus as a secondary product line. COA availability and verification have been reported as inconsistent by independent analysts.

Pricing Assessment

Score: 75/100 — Swisschems offers among the most competitive pricing in the peptide market. The low price point reflects honest positioning as a research chemical vendor rather than a supplement brand with premium marketing.

Regulatory Standing

Score: 40/100 — No FDA warning letters identified, but the “research use only” business model faces increasing legal scrutiny. The FDA has explicitly stated that “for research purposes only” disclaimers are “a ruse to avoid FDA scrutiny” when products are marketed with dosing guidance, testimonials, or bundled with injection supplies. Criminal precedent exists: All American Peptide owners forfeited over $3 million for similar operations (2014–2019). The Iceland domain suggests awareness of jurisdictional risk.

Customer Experience

Score: 55/100 — Trustpilot approximately 3.8/5 — moderate. Reddit reputation is generally positive for SARMs, with the community considering them a “dependable” source, though not a peptide specialist.

Red Flags

1. “Research use only” legal risk: This model faces increasing FDA scrutiny and criminal precedent
2. Inconsistent COA verification: Reports of lab verification not being available
3. Not a peptide specialist: SARMs are the core business; peptides are secondary
4. Iceland domain: May indicate awareness of US jurisdictional risk
5. Research chemical format: Products require reconstitution and sterile technique — user error risk

The Bottom Line

Swisschems represents a transparent trade-off: much lower pricing in exchange for a research chemical format that requires more user knowledge (reconstitution, sterile technique, dosing calculation). For consumers who understand these requirements, the competitive pricing is a genuine advantage. However, the legal risk of the “research use only” model is real and growing — the FDA has established criminal precedent against similar vendors. If you choose to buy from research chemical vendors, understand that you’re accepting both the quality risk of unregulated products and the legal risk of purchasing compounds the FDA considers misbranded.